NTSR1 — Neurotensin Receptor 1

NTSR1 — Neurotensin Receptor 1

Introduction

The NTSR1 gene (Neurotensin Receptor 1) encodes a G protein-coupled receptor (GPCR) that binds the neuropeptide neurotensin (NT) with high affinity (Kd ~ 0.1 nM). NTSR1 is a Class A rhodopsin-like GPCR that couples primarily to Gq proteins, activating phospholipase C (PLC) and leading to protein kinase C (PKC) activation, calcium mobilization, and MAPK/ERK signaling pathway activation. In the brain, NTSR1 is highly expressed in regions rich in dopaminergic neurons, where it plays a critical role in modulating [dopamine signaling](/mechanisms/dopamine-signaling) andMotor control[@vincent1995][@stgelais2004].

The neurotensin system has been increasingly recognized for its involvement in neurodegenerative diseases, particularly [Parkinson's disease](/diseases/parkinsons-disease) (PD) where NTSR1 modulates dopaminergic neuron survival and function. Additionally, NTSR1 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) (AD), schizophrenia, and various cancers. The receptor represents a promising therapeutic target, with both agonists and antagonists under investigation for neurological disorders[@bjornstrom2018][@yang2020].

NTSR1 — Neurotensin Receptor 1

Introduction

The NTSR1 gene (Neurotensin Receptor 1) encodes a G protein-coupled receptor (GPCR) that binds the neuropeptide neurotensin (NT) with high affinity (Kd ~ 0.1 nM). NTSR1 is a Class A rhodopsin-like GPCR that couples primarily to Gq proteins, activating phospholipase C (PLC) and leading to protein kinase C (PKC) activation, calcium mobilization, and MAPK/ERK signaling pathway activation. In the brain, NTSR1 is highly expressed in regions rich in dopaminergic neurons, where it plays a critical role in modulating [dopamine signaling](/mechanisms/dopamine-signaling) andMotor control[@vincent1995][@stgelais2004].

The neurotensin system has been increasingly recognized for its involvement in neurodegenerative diseases, particularly [Parkinson's disease](/diseases/parkinsons-disease) (PD) where NTSR1 modulates dopaminergic neuron survival and function. Additionally, NTSR1 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) (AD), schizophrenia, and various cancers. The receptor represents a promising therapeutic target, with both agonists and antagonists under investigation for neurological disorders[@bjornstrom2018][@yang2020].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Neurotensin Receptor 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>NTSR1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Neurotensin Receptor 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>2q24.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[4919](https://www.ncbi.nlm.nih.gov/gene/4919)</td></tr>
<tr><td><strong>OMIM</strong></td><td>162650</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000102468</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P21439](https://www.uniprot.org/uniprot/P21439)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Parkinson's Disease, Alzheimer's Disease, Schizophrenia, Cancer</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The NTSR1 gene is located on chromosome 2q24.1 and spans approximately 30 kilobases. It consists of multiple exons that encode a GPCR protein of approximately 418 amino acids.

| Property | Value |
|----------|-------|
| Gene Symbol | NTSR1 |
| Chromosomal Location | 2q24.1 |
| NCBI Gene ID | 4919 |
| Ensembl ID | ENSG00000102468 |
| UniProt | P21439 |
| RefSeq | NM_002531 |

Protein Structure

The NTSR1 protein contains the classic seven-transmembrane domain structure of Class A GPCRs:

Recent cryo-EM structures have revealed the detailed molecular interactions between NTSR1 and neurotensin, providing insights for rational drug design[@tang2022].

Neurotensin Signaling Pathways

Primary Gq Signaling Cascade

NTSR1 activation initiates multiple signaling cascades:

Gq-PLC Pathway:

MAPK/ERK Pathway:

• NTSR1 activates via Gq and β-arrestin
• Leads to ERK1/2 phosphorylation
• Regulates gene expression and cell survival

Secondary Signaling Pathways

Beyond Gq, NTSR1 can activate:

| Pathway | Mechanism | Cellular Effects |
|---------|-----------|------------------|
| PI3K/AKT | Gq-dependent and β-arrestin | Cell survival |
| JNK | Gq-dependent | Stress response |
| p38 MAPK | β-arrestin | Inflammation |
| RhoA | G12/13 coupling | Cytoskeletal dynamics |

Receptor Regulation

NTSR1 signaling is tightly controlled:

• Phosphorylation: G protein-coupled receptor kinases (GRKs) phosphorylate the receptor
• β-arrestin recruitment: Mediates desensitization and internalization
• Internalization: Clathrin-dependent endocytosis regulates surface expression
• Recycling: Return to membrane or degradation in lysosomes

Expression Pattern in the Central Nervous System

Regional Distribution

NTSR1 exhibits high expression in brain regions associated with motor control and reward:

• Substantia nigra (pars compacta): Highest expression in dopaminergic neurons
• Ventral tegmental area: Moderate expression in mesolimbic dopamine neurons
• Hypothalamus: High expression in regions controlling homeostasis
• Amygdala: Involved in emotional processing
• Hippocampus: Moderate expression in CA regions
• Cortex: Layer-specific expression, particularly layer 5

Cellular Localization

• Neurons: Primary cellular expression in the CNS
• Dopaminergic neurons: Particularly high expression in substantia nigra
• Glia: Lower expression, primarily in activated microglia during inflammation

Disease Associations

Parkinson's Disease

NTSR1 is centrally involved in PD pathophysiology:

Dopaminergic Modulation: NTSR1 activation modulates dopamine synthesis, release, and receptor signaling. The substantia nigra has particularly high NTSR1 expression, making it a key regulator of dopaminergic neuron function[@bjornstrom2018][@liu2019].

Neuroprotection: NTSR1 agonists have shown neuroprotective effects in multiple models:

• Protecting dopaminergic neurons from 6-OHDA toxicity
• Reducing MPTP-induced parkinsonism
• Improving behavioral outcomes in animal models

• Activation of survival pathways (PI3K/AKT, MAPK/ERK)
• Reduction of oxidative stress
• Inhibition of mitochondrial apoptosis
• Anti-inflammatory effects in microglia[@liu2019][@yang2020]

Alzheimer's Disease

NTSR1 contributes to AD through several mechanisms:

Cholinergic Modulation: NTSR1 influences cholinergic neurotransmission, which is prominently affected in AD

Amyloid Interaction: Neurotensin levels are altered in AD brain, potentially affecting amyloid metabolism

Synaptic Dysfunction: NTSR1 signaling modulates synaptic plasticity, which is impaired in AD

Neuroinflammation: NTSR1 in microglia may contribute to neuroinflammatory processes[@kim2020]

Schizophrenia

NTSR1 has been studied in relation to schizophrenia:

Dopamine Hypothesis Link: Given the close interaction between neurotensin and dopamine systems, NTSR1 may modulate dopamine dysregulation in schizophrenia

Therapeutic Target: NTSR1 antagonists have been explored as potential antipsychotics

Genetic Associations: Some studies link NTSR1 polymorphisms with schizophrenia risk

Cancer

Beyond the CNS, NTSR1 is implicated in cancer:

• Pancreatic cancer: High NTSR1 expression promotes tumor growth
• Colon cancer: NT-NTSR1 signaling enhances proliferation
• Lung cancer: NTSR1 contributes to metastasis

Molecular Mechanisms in Neurodegeneration

Dopaminergic Neuron Survival

NTSR1 signaling promotes dopaminergic neuron survival through multiple mechanisms:

Neuroinflammation

NTSR1 modulates neuroinflammatory responses:

• Microglial activation: NTSR1 expressed in microglia can regulate inflammatory cytokine production
• Anti-inflammatory effects: Agonist activation can reduce pro-inflammatory responses
• Cross-talk with dopamine: Inflammation and dopamine signaling interact bidirectionally[@chen2021]

Synaptic Transmission

NTSR1 modulates synaptic function in the substantia nigra:

• Presynaptic effects: Modulates dopamine release
• Postsynaptic effects: Alters receptor signaling
• Network-level impacts: Affects basal ganglia circuit function[@zhang2021]

Therapeutic Implications

NTSR1 Agonists

NTSR1 agonists are being developed for PD and other disorders:

| Compound | Stage | Key Features |
|----------|-------|--------------|
| PD-149163 | Research | Brain-penetrant agonist |
| ABS-201 | Preclinical | Selective for NTSR1 |
| SB-612422 | Research | NTSR1/NTSR2 selective |

Agonist benefits in PD:

• Neuroprotection of dopaminergic neurons
• Improved motor function in models
• Potential disease modification[@yang2020][@cruz2023]

NTSR1 Antagonists

Antagonists have different therapeutic applications:

• Psychiatric disorders: Potential antipsychotic effects
• Cancer: Blocking tumor growth
• Pain: NTSR1 contributes to pain signaling

Challenges

Developing NTSR1-targeted therapies faces several challenges:

Animal Models

Genetic Models

• Ntsr1 knockout mice: Viable with behavioral phenotypes
• Conditional KO: Region-specific deletion
• Transgenic overexpression: Neuronal overexpression models

Disease Models

• 6-OHDA lesions: NTSR1 agonists protect against toxicity
• MPTP model: Reduced degeneration with NTSR1 activation
• α-Synuclein models: Effects on pathology under investigation

Behavioral Studies

• Motor coordination: NTSR1 affects rotarod performance
• Exploratory behavior: Altered novelty responses
• Learning and memory: Context-dependent effects

Research Directions

Emerging Areas

• Structure-based drug design: Using cryo-EM structures for agonist/antagonist development
• β-arrestin biased signaling: Targeting specific downstream pathways
• Allosteric modulators: Developing subtype-selective compounds
• Gene therapy: Viral vector-mediated NTSR1 modulation

Clinical Trials

No current clinical trials for NTSR1 in PD, but preclinical data support advancement:

• Rationale: Strong neuroprotection in animal models
• Gap: Translation from rodent to human studies needed
• Opportunity: Biomarker development for patient selection

Biomarker Development

• NTSR1 imaging: PET ligands for receptor visualization
• CSF neurotensin: Potential biomarker
• Genetic markers: NTSR1 polymorphisms for patient stratification

Cross-Links

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Dopamine Signaling](/mechanisms/dopamine-signaling)
• [Substantia Nigra Dopamine Neurons](/cell-types/substantia-nigra-dopamine-neurons)
• [NTS Gene](/genes/nts)
• [GPCR Signaling in Neurodegeneration](/mechanisms/gpcr-signaling)
• [Neuroprotection](/mechanisms/neuroprotection-pathways)

References